Karyopharm Therapeutics Inc (KPTI) valuation · rev $146.1M
Karyopharm Therapeutics Inc (KPTI) rev $146.1M.
| Metric | Value |
|---|---|
| Market cap | $205.6M |
| Revenue | $146.1M |
| P/S | 1.4 |
KPTI valuation FAQ
What is KPTI's market cap?
Karyopharm Therapeutics Inc (KPTI) market cap is $205.6M on the latest cached fundamentals snapshot.
What is KPTI's latest revenue?
Latest cached Karyopharm Therapeutics Inc (KPTI) revenue was $146.1M. Statements: https://lician.com/financials/kpti
What is KPTI's price-to-sales ratio?
Karyopharm Therapeutics Inc (KPTI) price-to-sales (P/S) is 1.4, cached market cap $205.6M divided by revenue $146.1M.
How many KPTI valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Karyopharm Therapeutics Inc (KPTI): Market cap, Revenue, and P/S.
Where is KPTI valuation listed?
Cached valuation multiples for Karyopharm Therapeutics Inc (KPTI) are listed at https://lician.com/valuation/kpti.
Not investment advice. Cached rows, not a live tape.